Kovács, Z.M.; Óvári, J.; Dienes, C.; Magyar, J.; Bányász, T.; Nánási, P.P.; Horváth, B.; Feher, A.; Varga, Z.; Szentandrássy, N.
ABT-333 (Dasabuvir) Increases Action Potential Duration and Provokes Early Afterdepolarizations in Canine Left Ventricular Cells via Inhibition of IKr. Pharmaceuticals 2023, 16, 488.
https://doi.org/10.3390/ph16040488
AMA Style
Kovács ZM, Óvári J, Dienes C, Magyar J, Bányász T, Nánási PP, Horváth B, Feher A, Varga Z, Szentandrássy N.
ABT-333 (Dasabuvir) Increases Action Potential Duration and Provokes Early Afterdepolarizations in Canine Left Ventricular Cells via Inhibition of IKr. Pharmaceuticals. 2023; 16(4):488.
https://doi.org/10.3390/ph16040488
Chicago/Turabian Style
Kovács, Zsigmond Máté, József Óvári, Csaba Dienes, János Magyar, Tamás Bányász, Péter P. Nánási, Balázs Horváth, Adam Feher, Zoltan Varga, and Norbert Szentandrássy.
2023. "ABT-333 (Dasabuvir) Increases Action Potential Duration and Provokes Early Afterdepolarizations in Canine Left Ventricular Cells via Inhibition of IKr" Pharmaceuticals 16, no. 4: 488.
https://doi.org/10.3390/ph16040488
APA Style
Kovács, Z. M., Óvári, J., Dienes, C., Magyar, J., Bányász, T., Nánási, P. P., Horváth, B., Feher, A., Varga, Z., & Szentandrássy, N.
(2023). ABT-333 (Dasabuvir) Increases Action Potential Duration and Provokes Early Afterdepolarizations in Canine Left Ventricular Cells via Inhibition of IKr. Pharmaceuticals, 16(4), 488.
https://doi.org/10.3390/ph16040488